Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ: ILMN )

100.24 -1.54 (-1.51%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
31 32 Next >
Why Illumina Inc Stock Is Falling
llumina, Inc. (NASDAQ: ILMN) shares are trading lower Friday after the company reported mixed third-quarter financial results on Thursday. 
Via Benzinga
DNA-Reading Giant Illumina Crashes As Macro Pressures Guidance — Again
Illumina expects flat growth in 2024, which lines up with other life sciences tools companies. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Synaptics To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
US Stocks Could Wobble As Powell's Inflation Obsession Intensifies Rate Uncertainty: Will Nasdaq Wipe Off Week's Gains?
U.S. stocks are priming for a lackluster open on Friday, with the index futures trading on a narrowly mixed note. Interest rate worries have likely perked up, as reflected by the upward move in bond... 
Via Benzinga
Topics Bonds Economy
Exposures Debt Markets Interest Rates
Where Illumina Stands With Analysts
Via Benzinga
Expert Ratings for Illumina
Via Benzinga
Unity Software, Groupon, Trade Desk And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures traded mixed this morning on Friday, with the Dow Jones futures gaining around 40 points this morning. Shares of Unity Software Inc. (NYSE: U) fell sharply in pre-market trading... 
Via Benzinga
Topics Stocks
Exposures US Equities
Wall Street To Snap Longest Winning Streak Since 2021 Today? Earnings, Bond Yields In Focus Ahead Of Powell's Speech
The stock market’s momentum appears to be waning, and futures suggest a mixed opening for Thursday. Earnings reports have generally been positive, with companies like Walt Disney Co. 
Via Benzinga
6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367%
Wall Street is forever optimistic about the future for stocks and pegs these seven Nasdaq 100 stocks as ready for supersonic growth 
Via InvestorPlace
Jim Cramer Highlights Key Earnings To Watch In The Energy Sector This Coming Week: 'Bullish Herd To Continue To Thunder'
CNBC market analyst Jim Cramer outlined the critical financial events and earnings disclosures anticipated in the upcoming week, spotlighting oil and gas companies such as Coterra Energy Inc. 
Via Benzinga
The Law Offices of Frank R. Cruz Continues Its Investigation of Illumina, Inc. (ILMN) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Illumina, Inc. (ILMN) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
7 F-Rated Stocks to Sell Before November
Get rid of these F-rated stocks to sell so you can put that money into more lucrative opportunities in November. 
Via InvestorPlace
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:BNTX),(NASDAQ:SGEN),(NASDAQ:MYGN),(NASDAQ:ILMN) EQNX::TICKER_END 
Via FinancialNewsMedia
Exposures Product Safety
3 Nasdaq-100 Stocks Trading Less Than 10x 2024 Earnings
These three Nasdaq-100 stocks can be had for less than 10x 2024 earnings - extra compelling given that Wall Street expects Nasdaq profits will grow next year. 
Via MarketBeat
Topics Bonds Economy
Exposures Debt Markets Interest Rates
ChatGPT Parent OpenAI Aims At Budget-Friendly AI Innovations, Novo Nordisk's Popular Diabetes Drug Ozempic Faces Counterfeit Threat in Germany: Today's Top Stories
Bloomberg Apple and Suppliers Face Unanticipated Sales Slump Despite New Launches 
Via Benzinga
Topics Artificial Intelligence Supply Chain
Exposures Artificial Intelligence Supply Chain
Will Illumina Give Up Cancer Test Maker Grail? Mulls $8B Acquisition's Fate Amid Antitrust Pressure
Illumina Inc (NASDAQ: ILMN) reportedly said it will divest its controversial acquisition of Grail as expeditiously as possible if the life sciences company loses either of the final appeals in U.S. or... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Bear Of The Day: Illumina
Illumina, the maker of million-dollar genome sequencing machines that revolutionized the fields of genetics and biotechnology, has fallen hard in the past year. 
Via Talk Markets
Illumina Faces Mounting Pressure from Regulators Over $8B Grail Acquisition
The European Union regulators are set to order Illumina Inc (NASDAQ: ILMN) to divest its acquisition of  
Via Benzinga
3 Undervalued Healthcare Stocks to Watch as Sector Struggles
As the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth. 
Via MarketBeat
Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Nike To Rally Around 53%? Here Are 10 Other Analyst Forecasts For Friday
Piper Sandler cut the price target for Accenture plc (NYSE: ACN) from $312 to $300. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating. Accenture shares rose 0.3% to $301.56 in pre-market... 
Via Benzinga
September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average
The September market downturn is spreading like wildfire across various sectors, with only a handful of stocks managing to maintain the positive trend seen in recent months. 
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
Via Benzinga
Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test 
From Myriad Genetics, Inc.
Via GlobeNewswire
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback